| Moderated By: Geney -- (Moderated) -- Started: 8/2/2012 2:39:42 PM Revision History |
Here's a great article on ONCS which discusses their OMS Electroporation technology.
The company uses the process of electroporation, which is the use of electrical currents to increase the porosity of tumors allowing greater penetration of the cancer agent into the targeted tumor. The company’s novel concept is used for two different approaches to attack cancer tumors, ElectroImmunotherapy (initiating 3 Phase II studies) and ElectroChemotherapy. The company recently announced positive data on its Phase III study and showed a positive safety profile and efficacy.
The company’s platform is based on the hope that electroporation increases the tumor’s uptake of anti-cancer agents with the procedure being simple, safe, localized, and targeted, therefore making it effective. In theory it would save on cost and require low dosing, which then reduces and possibly eliminates toxicity.